Eye cancer, Melanoma, Melanoma of the eye, Secondary cancers
Results
Phase 2
This trial looked at imatinib (Glivec) for a type of melanoma of the eye (uveal melanoma) that had spread to another part of the body and couldn’t be removed with an operation. This is called advanced melanoma of the eye. This trial was for people whose melanoma cells, had a large amount of a protein called c-kit.
This trial was supported by Cancer Research UK.
Recruitment start: 19 August 2008
Recruitment end: 7 January 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ernie Marshall
Cancer Research UK
Clatterbridge Cancer Centre NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/07/042.
Last reviewed: 26 Sept 2013
CRUK internal database number: 2432
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
